COVID-19 thyroid disorders

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:

Overview

Many covid-19 patients eventually develop thyroid disorders. 90% of them develop hyperthyroidism, while the rest of them develop hypothyroidism.^[1]

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating ((Page name)) from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography or Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

References

↑ Boelaert K, Visser WE, Taylor PN, Moran C, Léger J, Persani L (2020). "ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of hyperthyroidism and hypothyroidism". Eur J Endocrinol. 183 (1): G33–G39. doi:10.1530/EJE-20-0445. PMC 7938012 Check |pmc= value (help). PMID 32438340 Check |pmid= value (help).

[pmid32438340-1] Boelaert K, Visser WE, Taylor PN, Moran C, Léger J, Persani L (2020). "ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of hyperthyroidism and hypothyroidism". Eur J Endocrinol. 183 (1): G33–G39. doi:10.1530/EJE-20-0445. PMC 7938012 Check |pmc= value (help). PMID 32438340 Check |pmid= value (help).

[1]